Abdel Kareem Azab

15PUBLICATIONS
34CO-AUTHORS
Cardiology (incl. cardiovascular diseases)Medical infection agents (incl. prions)NanomedicineMolecular targetsApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (15)

|Jun 16, 2026
Targeted degradation of CBP/p300 by CBPD-409 exhibits robust anti-myeloma activity.

|Aug 30, 2024
IL-10R inhibition reprograms tumor-associated macrophages and reverses drug resistance in multiple myeloma.

Jennifer Sun, Stefan Corradini, Feda Azab

|Apr 07, 2023
E-selectin-targeting lipid nanoparticles improve therapeutic efficacy and reduce side effects of bortezomib in multiple myeloma.

Mina Maksimos, Barbara Muz, John L Magnani

|Nov 18, 2022
An mTORC1 to HRI signaling axis promotes cytotoxicity of proteasome inhibitors in multiple myeloma.

Odai Darawshi, Barbara Muz, Shiri Gershon Naamat

|Jul 19, 2022
BRD9 degraders as chemosensitizers in acute leukemia and multiple myeloma.

Ellen Weisberg, Basudev Chowdhury, Chengcheng Meng

|Jan 11, 2022
Liposomal phytohemagglutinin: In vivo T-cell activator as a novel pan-cancer immunotherapy.

Kinan Alhallak, Jennifer Sun, Barbara Muz

Pageof 3

Frequent Collaborators

4 joint publications

Barbara Muz

2 joint publications

Stefan Corradini

2 joint publications

Noha Nabil Salama

2 joint publications

Mark T S Williams